메뉴 건너뛰기




Volumn 109, Issue 4, 2012, Pages 520-524

Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer

Author keywords

biochemical failure; localized prostate cancer; prediction; testosterone

Indexed keywords

GOSERELIN; TESTOSTERONE;

EID: 84857033892     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10335.x     Document Type: Article
Times cited : (30)

References (28)
  • 1
    • 69849101398 scopus 로고    scopus 로고
    • The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness
    • Morote J, Ramirez C, Gomez E, et al,. The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness. BJU Int 2009; 104: 486-9
    • (2009) BJU Int , vol.104 , pp. 486-489
    • Morote, J.1    Ramirez, C.2    Gomez, E.3
  • 2
    • 78449289245 scopus 로고    scopus 로고
    • Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: A nested case-control study
    • Sawada N, Iwasaki M, Inoue M, et al,. Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: a nested case-control study. Cancer Sci 2010; 101: 2652-7
    • (2010) Cancer Sci , vol.101 , pp. 2652-2657
    • Sawada, N.1    Iwasaki, M.2    Inoue, M.3
  • 3
  • 4
    • 34447094139 scopus 로고    scopus 로고
    • 9th edn. Wein A.J. Kavoussi L.R. Novick A.L. Partin A.W. Peters C.A. eds, Philadelphia: WB Saunders
    • Campbell MF, Wein AJ, Kavoussi LR,. Campbell-Walsh Urology, 9th edn., Wein AJ, Kavoussi LR, Novick AL, Partin AW, Peters CA, eds, Philadelphia: WB Saunders, 2007
    • (2007) Campbell-Walsh Urology
    • Campbell, M.F.1    Wein, A.J.2    Kavoussi, L.R.3
  • 5
    • 79955459178 scopus 로고    scopus 로고
    • Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer
    • Xylinas E, Ploussard G, Durand X, et al,. Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer. BJU Int 2011; 107: 1400-3
    • (2011) BJU Int , vol.107 , pp. 1400-1403
    • Xylinas, E.1    Ploussard, G.2    Durand, X.3
  • 6
    • 27744467589 scopus 로고    scopus 로고
    • Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: Hypogonadism represents bad prognosis in prostate cancer
    • DOI 10.1097/01.ju.0000181818.51977.29
    • Teloken C, Da Ros CT, Caraver F, Weber FA, Cavalheiro AP, Graziottin TM,. Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer. J Urol 2005; 174: 2178-80 (Pubitemid 41611769)
    • (2005) Journal of Urology , vol.174 , Issue.6 , pp. 2178-2180
    • Teloken, C.1    Teodosio Da Ros, C.2    Caraver, F.3    Weber, F.A.4    Cavalheiro, A.P.5    Graziottin, T.M.6
  • 8
    • 56449126893 scopus 로고    scopus 로고
    • Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy
    • Lane BR, Stephenson AJ, Magi-Galluzzi C, Lakin MM, Klein EA,. Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy. Urology 2008; 72: 1240-5
    • (2008) Urology , vol.72 , pp. 1240-1245
    • Lane, B.R.1    Stephenson, A.J.2    Magi-Galluzzi, C.3    Lakin, M.M.4    Klein, E.A.5
  • 10
    • 0015797193 scopus 로고
    • Circadian rhythm of plasma testosterone, cortisol and gonadotropins in normal male subjects
    • Piro C, Fraioli F, Sciarra F, Conti C,. Circadian rhythm of plasma testosterone, cortisol and gonadotropins in normal male subjects. J Steroid Biochem 1973; 4: 321-9
    • (1973) J Steroid Biochem , vol.4 , pp. 321-329
    • Piro, C.1    Fraioli, F.2    Sciarra, F.3    Conti, C.4
  • 11
    • 39149084101 scopus 로고    scopus 로고
    • Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
    • DOI 10.1093/jnci/djm323
    • Roddam AW, Allen NE, Appleby P, Key TJ,. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008; 100: 170-83 (Pubitemid 351480553)
    • (2008) Journal of the National Cancer Institute , vol.100 , Issue.3 , pp. 170-183
    • Roddam, A.W.1    Allen, N.E.2    Appleby, P.3    Key, T.J.4
  • 12
    • 18744369944 scopus 로고    scopus 로고
    • Testosterone as a predictor of pathological stage in clinically localized prostate cancer
    • DOI 10.1097/01.ju.0000158040.33531.e7
    • Isom-Batz G, Bianco FJ Jr, Kattan MW, Mulhall JP, Lilja H, Eastham JA,. Testosterone as a predictor of pathological stage in clinically localized prostate cancer. J Urol 2005; 173: 1935-7 (Pubitemid 40675215)
    • (2005) Journal of Urology , vol.173 , Issue.6 , pp. 1935-1937
    • Isom-Batz, G.1    Blanco Jr., F.J.2    Kattan, M.W.3    Mulhall, J.P.4    Lilja, H.5    Eastham, J.A.6
  • 15
    • 0032038146 scopus 로고    scopus 로고
    • Recent progress in our understanding of inhibin in the prostate gland
    • Risbridger GP,. Recent progress in our understanding of inhibin in the prostate gland. J Endocrinol 1998; 157: 1-4
    • (1998) J Endocrinol , vol.157 , pp. 1-4
    • Risbridger, G.P.1
  • 16
    • 60349097318 scopus 로고    scopus 로고
    • Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?
    • Imamoto T, Suzuki H, Yano M, et al,. Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients? Prostate Cancer Prostatic Dis 2009; 12: 78-82
    • (2009) Prostate Cancer Prostatic Dis , vol.12 , pp. 78-82
    • Imamoto, T.1    Suzuki, H.2    Yano, M.3
  • 17
    • 0018975785 scopus 로고
    • Total and SHBG-bound testosterone and 5α-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma
    • Lukkarinen O,. Total and SHBG-bound testosterone and 5 alpha-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma. Br J Urol 1980; 52: 377-80 (Pubitemid 10010928)
    • (1980) British Journal of Urology , vol.52 , Issue.5 , pp. 377-380
    • Lukkarinen, O.1
  • 18
    • 0037377311 scopus 로고    scopus 로고
    • Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer
    • DOI 10.1097/01.ju.0000056900.26628.16
    • Schatzl G, Madersbacher S, Haitel A, et al,. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer. J Urol 2003; 169: 1312-5 (Pubitemid 36323774)
    • (2003) Journal of Urology , vol.169 , Issue.4 , pp. 1312-1315
    • Schatzl, G.1    Madersbacher, S.2    Haitel, A.3    Gsur, A.4    Preyer, M.5    Haidinger, G.6    Gassner, C.7    Ochsner, M.8    Marberger, M.9
  • 20
    • 0343048346 scopus 로고    scopus 로고
    • Endocrine status in elderly men with lower urinary tract symptoms: Correlation of age, hormonal status, and lower urinary tract function
    • DOI 10.1016/S0090-4295(99)00473-2, PII S0090429599004732
    • Schatzl G, Brossner C, Schmid S, et al,. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology. Urology 2000; 55: 397-402 (Pubitemid 30110593)
    • (2000) Urology , vol.55 , Issue.3 , pp. 397-402
    • Schatzl, G.1    Brossner, C.2    Schmid, S.3    Kugler, W.4    Roehrich, M.5    Treu, T.6    Szalay, A.7    Djavan, B.8    Schmidbauer, C.P.9    Soregi, S.10    Madersbacher, S.11
  • 21
    • 0033950926 scopus 로고    scopus 로고
    • Is low serum free testosterone a marker for high grade prostate cancer?
    • Hoffman MA, DeWolf WC, Morgentaler A,. Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000; 163: 824-7 (Pubitemid 30091624)
    • (2000) Journal of Urology , vol.163 , Issue.3 , pp. 824-827
    • Hoffman, M.A.1    DeWolf, W.C.2    Morgentaler, A.3
  • 23
    • 0025884064 scopus 로고
    • Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study
    • Gray A, Feldman HA, McKinlay JB, Longcope C,. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73: 1016-25 (Pubitemid 21901140)
    • (1991) Journal of Clinical Endocrinology and Metabolism , vol.73 , Issue.5 , pp. 1016-1025
    • Gray, A.1    Feldman, H.A.2    McKinlay, J.B.3    Longcope, C.4
  • 26
    • 0029016831 scopus 로고
    • Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: Interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group
    • Van Poppel H, De Ridder D, Elgamal AA, et al,. Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group. J Urol 1995; 154: 429-34
    • (1995) J Urol , vol.154 , pp. 429-434
    • Van Poppel, H.1    De Ridder, D.2    Elgamal, A.A.3
  • 27
    • 0036828025 scopus 로고    scopus 로고
    • Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: A detailed analysis of radical prostatectomy specimens from a randomized trial
    • DOI 10.1097/00000478-200211000-00002
    • Bullock MJ, Srigley JR, Klotz LH, Goldenberg SL,. Pathologic effects of neoadjuvant cyproterone acetate on nonneoplastic prostate, prostatic intraepithelial neoplasia, and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial. Am J Surg Pathol 2002; 26: 1400-13 (Pubitemid 35239416)
    • (2002) American Journal of Surgical Pathology , vol.26 , Issue.11 , pp. 1400-1413
    • Bullock, M.J.1    Srigley, J.R.2    Klotz, L.H.3    Larry Goldenberg, S.4
  • 28
    • 0036381078 scopus 로고    scopus 로고
    • Three-month neoadjuvant hormonal therapy before radical prostatectomy: A 7-year follow-up of a randomized controlled trial
    • Aus G, Abrahamsson PA, Ahlgren G, et al,. Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial. BJU Int 2002; 90: 561-6
    • (2002) BJU Int , vol.90 , pp. 561-566
    • Aus, G.1    Abrahamsson, P.A.2    Ahlgren, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.